Efficacy of Radial Shockwave Therapy for Treatment of Pain in Knee Osteoarthritis

Sponsor
Marta Imamura (Other)
Overall Status
Completed
CT.gov ID
NCT02197962
Collaborator
University of Sao Paulo (Other)
105
2
2
67
52.5
0.8

Study Details

Study Description

Brief Summary

The objective of this study is to compare the results of 2000 impulses of radius shockwaves per week with 2000 placebo shockwaves on the treatment of pain and functional incapacity of patients with severe primary knee osteoarthritis, who did not satisfactory respond to previous conventional treatments.

Condition or Disease Intervention/Treatment Phase
  • Device: Extracorporeal Radial shockwaves
  • Device: Placebo Radial Shockwaves
Phase 2

Detailed Description

  • Prospective, placebo controlled randomized and double-blind study.

  • Treatment Method:

Radial extracorporeal shockwaves will be applied using the Swiss Dolorclast (EMS Electro Medical Systems, Switzerland), generated by pneumatic waves.

Intervention:
  • Group 1 - Intervention group Patients will receive 2,000 impulses of radial shockwave per week, with pressure of 2.5bar to 4.0bar, at the frequency of 8Hz. The impulses will be applied at the most painful site of the knee joint interface on manual palpation, for three consecutive weeks.

  • Group 2 - Control Group:

Patients will receive 2,000 impulses of placebo radial shockwave per week, without any energy flow intensity. Frequency of 8Hz will appear in the screen. The impulses will be applied at the most painful site of the knee joint interface on manual palpation, for three consecutive weeks.

Post application program for both groups: Three consecutive days of:
  1. Hot packs (superficial heat) applied on the application site for 20 minutes;

  2. Simple analgesics, when needed (Acetaminophen 500mg every 6 hours, or analogue in case of allergy).

Outcome Evaluation:

The evaluation of pain intensity will be done according to the VAS (Visual Analog Scale) The influence of pain on the functional capacity of patients will be measured with WOMAC (Western Ontario and McMaster Osteoarthritis Index) for knee evaluation.

Another evaluation criteria will be the level of tolerance of pressure on several muscles and other parts as the pes anserinus and patellar tendon, the knee joint interface, and the supraspinal of L1 to S1 also on the dermatomal from T12 to S2. These measures will be done by the Fisher algometry.

The evaluations will be carried out before the treatment, immediately after the treatment and 3 months after the end of the treatment.

Analgesia drut will be prescribed, if patients feel pain during the days after the application.

Study Design

Study Type:
Interventional
Actual Enrollment :
105 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
Efficacy of Radial Shockwave Therapy for Treatment of Pain in Knee Osteoarthritis
Study Start Date :
May 1, 2010
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Extracorporeal radial shockwaves

Patients will receive 2,000 impulses of extracorporeal radial shockwave per week, with pressure of 2.5bar to 4.0bar, at the frequency of 8Hz. The impulses will be applied at the most painful site of the knee joint interface on manual palpation, for three consecutive weeks.

Device: Extracorporeal Radial shockwaves
Patients will receive 2,000 impulses of extracorporeal radial shockwaves or per week, with pressure of 2.5bar to 4.0bar, at the frequency of 8Hz. The impulses will be applied at the most painful site of the knee joint interface on manual palpation, for three consecutive weeks.

Placebo Comparator: Placebo Radial Shockwaves

Patients will receive 2,000 impulses of placebo radial shockwave per week, without any energy flow intensity. Frequency of 8Hz will appear in the screen. The impulses will be applied at the most painful site of the knee joint interface on manual palpation, for three consecutive weeks.

Device: Placebo Radial Shockwaves
Patients will receive 2,000 impulses of placebo extracorporeal radial shockwaves per week, without any pressure, therefore no energy will be applied, at the frequency of 8Hz. The impulses will be applied at the most painful site of the knee joint interface on manual palpation, for three consecutive weeks.

Outcome Measures

Primary Outcome Measures

  1. Visual Analog Scale [Before intervention and after 3 months of the end of intervention]

    The Visual Analog Scale consists of a straight line of 10cm length which presents the phrase "absence of pain" (0) at one extremity, and unbearable pain (10) at the other extremity.

Secondary Outcome Measures

  1. Level of tolerance of pain [Immediately before the intervention, immediately after the intervention and 3 months after the intervention.]

    Measures will be taken with the Fisher algometry in the following muscles: vastus medialis, vastus lateralis, rectus femoris, gracilis, adductor longus, tibialis anterior, fibularis longus, quadratus lumborum, iliopsoas and popliteus; also at the pes anserinus and patellar tendon, the knee joint interface, the supraspinal of L1 to S1 and on the dermatomal from T12 to S2.

Other Outcome Measures

  1. The influence of pain over the functional capacity of patients based on the WOMAC questionnaire [Immediately before the intervention and 3 months after the intervention.]

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical and radiological diagnosis of primary knee diagnosis.

  • Pain intensity: Visual Analog Scale (VAS) ≥ 6;

  • One of more failures with conventional treatment (drugs, Non-Steroidal Anti-inflammatory Drugs - NSAD, physiotherapy, stretching, acupuncture, orthosis and others);

  • Age over 60 years;

  • No use of corticosteroids in the prior 48 hours;

  • No major osteoarthritis events in other joints of lower limbs (waist and ankle) and lower back;

  • No clinical evidence of related neuropathy, including radiculopathy and peripheral neuropathy;

  • Absence of systemic inflammatory disease (Rheumatoid arthritis, Reiter, ankylosing spondylitis, generalized polyarthritis, cancer);

  • Absence of infection or cancer at the application site;

  • Absence of related endocrine and metabolic diseases;

  • Absence of fibromyalgia, diagnosed after the American College of Rheumatology, 1999;

  • Absence of severe blood dyscrasias;

  • Absence of severe psychiatric disturbances that requires psychiatric assessment;

  • Availability to comply with the clinic visits and follow up evaluations along the treatment

Exclusion Criteria:
  • Patients who withdraw the informed consent form at any time

Contacts and Locations

Locations

Site City State Country Postal Code
1 Instituto de Ortopedia e Traumatologia HCFMUSP Sao Paulo Brazil 05403-010
2 Instituto de Medicina Fisica e Reabilitacao HCFMUSP Sao Paulo Brazil 05716-150

Sponsors and Collaborators

  • Marta Imamura
  • University of Sao Paulo

Investigators

  • Principal Investigator: Marta Imamura, MD, Instituto de Medicina Fisica e Reabilitacao HCFMUSP

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marta Imamura, Medical Doctor, University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT02197962
Other Study ID Numbers:
  • Radial Shockwave
First Posted:
Jul 23, 2014
Last Update Posted:
Oct 5, 2016
Last Verified:
Oct 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Marta Imamura, Medical Doctor, University of Sao Paulo
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2016